Datamonitor's ZymoGenetics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. ZymoGenetics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic protein-based products for the treatment of human diseases. The company's therapeutic emphasis is on the areas of hemostasis inflammatory diseases, cancer and viral infections. It primarily operates in the US. The company is headquartered in Seattle, Washington and employed 323 people as of December 2009. The company recorded revenues of $137 million during the financial year (FY) ended December 2009, an increase of 85.1% over FY2008. The increase in revenues was due to the sales of Recothrom and from collaborative agreement revenues. The operating loss of the company was $32.1 million during FY2009, as compared to an operating loss of $118.6 million in FY2008. The net loss was $43 million in FY2009, as compared to a net loss of $116.2 million in FY2008.Scope of the Report
Reasons to Purchase
- Provides all the crucial information on ZymoGenetics, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting ZymoGenetics, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of ZymoGenetics, Inc.
- Data is supplemented with details on ZymoGenetics, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from ZymoGenetics, Inc.
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available